News & Events category:
North Manchester General Hospital

An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.

On International Clinical Trials Day 2023, Karen Connolly, Clinical Research Practitioner shares her inspiring story of how she got into research and encourages others to do the same.

The world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.

Manchester University NHS Foundation Trust has just enrolled the first participants in a new HIV study using long-acting immune-based therapy.

Research finds interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination doubles antibody response.

A patient at Manchester University NHS Foundation Trust, is the first person in Europe to trial a new treatment for long-term (chronic) wounds.

People taking part in a vaccine study at Manchester University NHS Foundation Trust (MFT) have shared their motivations for taking part – in the hope others might be inspired to do the same.